Brief: Cyclo Therapeutics Reports Qtrly Net Loss Per Common Share $0.60
15/11/2021 22:19
Nov 15 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
THIRD
QUARTER 2021 FINANCIAL RESULTS
* CYCLO THERAPEUTICS - QTRLY BASIC AND DILUTED NET LOSS PER
COMMON SHARE $0.60
Source text for Eikon: ID:nBwHTdY3a
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug